Britten Gordon

BG

Statistics

Publications

1

Citations

12

H-Index

1

Active since

2024

Affiliations

Britten Gordon is an author at Stanford University specializing in cdk inhibitors, targeted cancer therapy, and canonical wnt beta-catenin pathway.

Publications per year

2024–2024

1

Publications

1